Rituximab for Children With Difficult-to-Treat Nephrotic Syndrome: Its Effects on Disease Progression and Growth

Background: Since the early 2000s rituximab (RTX) has been thought of as an alternative treatment for steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS). Objective: This study aimed to determine the effects of RTX treatment on disease outcome and growth in pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Topaloğlu, Rezan, Gülhan, Bora, Çelegen, Kübra, İnözü, Mihriban, Hayran, Mutlu, Düzova, Ali, Ozaltin, Fatih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682627/
https://www.ncbi.nlm.nih.gov/pubmed/31417883
http://dx.doi.org/10.3389/fped.2019.00313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682627/
https://www.ncbi.nlm.nih.gov/pubmed/31417883
http://dx.doi.org/10.3389/fped.2019.00313

Ejemplares similares